These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27759575)

  • 21. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.
    Hua L; Andersen JW; Daar ES; Glesby MJ; Hollabaugh K; Tierney C
    AIDS; 2013 Nov; 27(17):2725-34. PubMed ID: 23921611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects.
    Badano MN; Parodi C; Aloisi N; Corti M; Elizalde de Bracco MM; Baré P
    Med Microbiol Immunol; 2019 Dec; 208(6):747-756. PubMed ID: 31147782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
    Estrada V; Geijo P; Fuentes-Ferrer M; Alcalde ML; Rodrigo M; Galindo MJ; Muñoz A; Domingo P; Ribera E; Cosín J; Viciana P; Lozano F; Terrón A; Vergara A; Teira R; Muñoz-Sánchez J; Roca B; Sánchez T; López-Aldeguer J; Deig E; Vidal F; Pedrol E; Castaño-Carracedo M; Puig T; Garrido M; Suárez-Lozano I
    BMC Womens Health; 2011 Aug; 11():36. PubMed ID: 21816091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
    Baxi SM; Scherzer R; Greenblatt RM; Minkoff H; Sharma A; Cohen M; Young MA; Abraham AG; Shlipak MG;
    AIDS; 2016 Feb; 30(4):609-18. PubMed ID: 26558723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Dec; 26(12):3923-9. PubMed ID: 21427068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    Aibibula W; Cox J; Hamelin AM; Moodie E; Naimi AI; McLinden T; Klein MB; Brassard P
    HIV Med; 2018 Feb; 19(2):123-131. PubMed ID: 29094807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
    Prendergast AJ; Szubert AJ; Berejena C; Pimundu G; Pala P; Shonhai A; Musiime V; Bwakura-Dangarembizi M; Poulsom H; Hunter P; Musoke P; Kihembo M; Munderi P; Gibb DM; Spyer M; Walker AS; Klein N;
    J Infect Dis; 2016 Jul; 214(2):226-36. PubMed ID: 27190179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
    Colombo M; McGurnaghan SJ; Blackbourn LAK; Dalton RN; Dunger D; Bell S; Petrie JR; Green F; MacRury S; McKnight JA; Chalmers J; Collier A; McKeigue PM; Colhoun HM;
    Diabetologia; 2020 Apr; 63(4):788-798. PubMed ID: 31915892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection by HTLV-1 Is Associated With High Levels of Proinflammatory Cytokines in HIV-HCV-Coinfected Patients.
    Brites C; Abrahão M; Bozza P; Netto EM; Lyra A; Bahia F
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):230-234. PubMed ID: 29084047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
    Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
    BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
    Jotwani V; Scherzer R; Glidden DV; Mehrotra M; Defechereux P; Liu A; Gandhi M; Bennett M; Coca SG; Parikh CR; Grant RM; Shlipak MG
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):169-174. PubMed ID: 29767638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
    Villacres MC; Kono N; Mack WJ; Nowicki MJ; Anastos K; Augenbraun M; Liu C; Landay A; Greenblatt RM; Gange SJ; Levine AM
    J Infect Dis; 2012 Sep; 206(5):780-9. PubMed ID: 22693231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
    Tsui J; Vittinghoff E; Anastos K; Augenbraun M; Young M; Nowicki M; Cohen MH; Peters MG; Golub ET; Szczech L
    Am J Kidney Dis; 2009 Jul; 54(1):43-50. PubMed ID: 19394735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
    Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
    AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV antibodies level as a marker of HIV persistence: the role of hepatitis C virus coinfection.
    Arca-Suarez J; Corrales-Cuevas M; Pascual-Pérez S; Trujillo-Soto T; Fernández-Gutiérrez Del Álamo C; Cuesta-Sancho S; Rodríguez-Iglesias M; Girón-González JA
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1503-1512. PubMed ID: 32232689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.
    Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D;
    AIDS; 2014 May; 28(8):1155-60. PubMed ID: 24499953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.